Threshold Pharmaceuticals Newswire
Comprehensive Real-Time News Feed for Threshold Pharmaceuticals.
Results 1 - 20 of 90 in Threshold Pharmaceuticals
-
New Market Research Report: Neuroendocrine Tumors - Pipeline Review, H1 2013
... & Co., Inc. Delcath Systems, Inc. Ipsen S.A. Novartis AG Molecular Insight Pharmaceuticals, Inc. Threshold Pharmaceuticals, Inc. Nobelpharma Co., Ltd. Gradalis Inc. Neuroendocrine Tumors - Therapeutics Assessment Assessment by Monotherapy Products ... Comment?
-
Threshold Pharmaceuticals, Inc. Reports First Quarter 2013 Financial and Operational Results
Threshold Pharmaceuticals, Inc. , today reported financial results for the first quarter 2013. Comment?
-
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) Long-Term Investor Alert: Investigation announced
Investors who are current long term stockholders of shares of Threshold Pharmaceuticals, Inc. Comment?
-
Threshold Pharmaceuticals, Inc. Announces Presentation and Webcast at ...
Threshold Pharmaceuticals, Inc. today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present a company overview at the 12th Annual Needham Healthcare Conference on April 30, 2013, at 1:40 p.m. ET. Comment?
-
Threshold: My Biotech Pick Of The Year
... to look past that and actually decide which ones are contenders and which ones are pretenders. Threshold Pharmaceuticals ( THLD ) appears to be an undiscovered gem. Threshold Pharmaceuticals is a clinical stage biopharmaceutical company focused on ... Comment?
-
Ambit Biosciences Appoints to Board of Directors
Dr. Parkinson is a venture partner at New Enterprise Associates, a position he has held since 2012, and a member of the board of directors for Threshold Pharmaceuticals, a publicly-traded oncology company, and Zyngenia, Inc. Comment?
-
Ambit Biosciences Names Venture Partner To Board
... named David R. Parkinson, M.D. to its board of directors; Parkinson also serves on the board of Threshold Pharmaceuticals and Zyngenia, in addition to previously sitting on the boards of Facet Biotech. He was previously CEO and President of Nodality ... Comment?
-
Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
... Associates, a position he has held since 2012, and a member of the board of directors for Threshold Pharmaceuticals, a publicly-traded oncology company, and Zyngenia, Inc. He served as a director of Facet Biotech through its acquisition by Abbott in ... Comment?
-
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD) Long-Term Investor Alert: Investigation Announced
An investigation on behalf of investors in shares of Threshold Pharmaceuticals, Inc. Comment?
-
High option volume stocks: Anw THLD Agco Agco Irwd
... maintains a Buy rating on Synergy. Threshold higher after Ziopharm terminates STS drug development Threshold Pharmaceuticals (THLD) shares are trading higher today after rival cancer drug discovery company Ziopharm (ZIOP) terminated its development ... Comment?
-
New Market Research Report: Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2013
... PLC Eli Lilly and Company Plexxikon Inc. Novartis AG SuperGen, Inc. Bayer AG AEterna Zentaris Inc. Threshold Pharmaceuticals, Inc. Synta Pharmaceuticals Corp. Chipscreen Biosciences Ltd Ambit Biosciences Corporation Deciphera Pharmaceuticals, LLC AB ... Comment?
-
Market Report, "Metastatic Pancreatic Cancer - Pipeline Review, H1 2013", published
... Halozyme Therapeutics Momenta Pharmaceuticals, Inc. IMMUNOMEDICS, INC Oncolytics Biotech Inc. Threshold Pharmaceuticals, Inc. Synta Pharmaceuticals Corp. NanoCarrier Co., Ltd. Rexahn Pharmaceuticals, Inc. Colby Pharmaceutical Company INSYS ... Comment?
-
Now Available: Adenocarcinoma - Pipeline Review, H1 2013
... Merck KGaA Celldex Therapeutics, Inc. Lorus Therapeutics Inc Peregrine Pharmaceuticals, Inc. Threshold Pharmaceuticals, Inc. GANYMED Pharmaceuticals AG MacroGenics, Inc. BioCancell Therapeutics, Inc. Kinex Pharmaceuticals, LLC Eleison ... Comment?
-
Shareholder Alert: The Law Firm of Levi & Korsinsky, LLP Launches an...
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Threshold Pharmaceuticals Inc. Comment?
-
NASDAQ Gainers Watch List: Raptor Pharmaceuticals Corp....
... Watch List adding Raptor Pharmaceuticals Corp. (NASDAQ:RPTP), Dendreon Corp. (NASDAQ:DNDN), and Threshold Pharmaceuticals Inc. (NASDAQ:THLD). Raptor Pharmaceuticals Corp. (NASDAQ:RPTP) operates as a development stage biotechnology company in the ... Comment?
-
4 Unique Nonwinners Share: THLD, BAS, BGCP, YGE
Threshold Pharmaceuticals Inc. is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in the microenvironments of most solid tumors as well as the bone marrows of some patients with hematologic malignancies. Comment?
-
Threshold Pharmaceuticals, Inc. Announces Presentation and Webcast at the 20th Annual
Threshold Pharmaceuticals, Inc. today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present a company overview at the 20th Annual Future Leaders in the Biotechnology Industry Conference at 8:30 a.m. ET on Friday, April 5, 2013. Comment?
-
US Stocks Review: Threshold Pharmaceuticals, CIBER, Quicksilver Resources Inc, Tumi Holdings Inc
Bestdamnpennystocks , an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:- Threshold Pharmaceuticals, Inc. Comment?
-
Aastrom Biosciences, Inc. (NASDAQ:ASTM), BioSante Pharmaceuticals,...
... List adding Aastrom Biosciences, Inc. (NASDAQ:ASTM), BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX), Threshold Pharmaceuticals Inc. (NASDAQ:THLD), and Venaxis, Inc. (NASDAQ:APPY). Aastrom Biosciences, Inc. (NASDAQ:ASTM) a development stage company ... Comment?
-
Stocks with implied volatility below IV index mean; Ziop STZ
... up 6.36, or 0.41%, to 1,558.05. Threshold higher after Ziopharm terminates STS drug development Threshold Pharmaceuticals (THLD) shares are trading higher today after rival cancer drug discovery company Ziopharm (ZIOP) terminated its development of ... Comment?
Threshold Pharmaceuticals Forum
| Topic | Comments |
|---|---|
| Way oversold Threshold pharma | 1 |
Most Popular
- Obama: There's no longer room for excuses for black men - 102 comments
- Soldier killed in attack near London barracks, lawmaker says - 156 comments
- Ogdensburg officer faces harassment charge in Canton - 46 comments
- Republican Issa to call IRS's Lerner back in Tea Party probe - 50 comments
- Inhofe: Tornado 'totally different' from Hurricane Sandy - 66 comments
- Evasive Answers?Irs Official Facing More Scrutiny Over Scandal, Past - 93 comments
- Suspected Muslim terrorists hack man to death - 40 comments
- Irishman charged with 1982 IRA Hyde Park bombing - 44 comments
- US Boy Scouts to Admit Openly Gay Youths as Members - 28 comments
- Attorney General Holder: Drones killed 4 Americans since 2009 - 39 comments
Copyright ©2013 Topix LLC
